Brief: Homology Medicines Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
03/01/2024 21:10
Jan 3 (Reuters) - Homology Medicines Inc FIXX.O :
* HOMOLOGY MEDICINES RECEIVES NASDAQ NOTIFICATION REGARDING
MINIMUM BID PRICE DEFICIENCY
Source text for Eikon: ID:nGNX7fKSrk
Further company coverage: FIXX.O
Recent news on Q32 Bio
See all newsNASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Q32 Bio Reports Second Quarter 2026 Financial Results And Provides Corporate Update
Q32 Bio Inc. reports results for the quarter ended June 30 - Earnings Summary
Q32 Bio Inc expected to post a loss of 54 cents a share - Earnings Preview